Clinical Trial Update: Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing a combination of Taxotere (docetaxel), cisplatin, and irinotecan (CPT-11) in adults with advanced solid tumors. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• CISPLATIN (cisplatin)
• CPT-11 (Irinotecan)
• Taxotere (docetaxel)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED